NUCLEUS HYBRID L24 CI24RE (L24) N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2019-04-08 for NUCLEUS HYBRID L24 CI24RE (L24) N/A manufactured by Cochlear Ltd.

Event Text Entries

[141304584] (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[141304585] Per the clinic, the patient experienced infection at implant site and was treated with oral and iv antibiotics, following treatment the patient was placed under general anaesthetic to undergo skin revision surgery. The implanted device remains.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000034-2019-00497
MDR Report Key8494228
Report SourceHEALTH PROFESSIONAL
Date Received2019-04-08
Date of Report2019-07-05
Date Mfgr Received2019-07-05
Device Manufacturer Date2018-01-09
Date Added to Maude2019-04-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. KRISTEL KOHNE
Manufacturer Street1 UNIVERSITY AVENUE
Manufacturer CityMACQAURIE UNIVERSITY, NSW 2109
Manufacturer CountryAS
Manufacturer Postal2109
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUCLEUS HYBRID L24
Generic NameNUCLEUS HYBRID COCHLEAR IMPLANT SYSTEM
Product CodePGQ
Date Received2019-04-08
Returned To Mfg2019-06-24
Model NumberCI24RE (L24)
Catalog NumberN/A
Lot NumberN/A
OperatorLAY USER/PATIENT
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCOCHLEAR LTD
Manufacturer Address1 UNIVERSITY AVENUE MACQUARIE UNIVERSITY, NSW 2109 AS 2109


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-04-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.